論文・総説 - 石川　欽也

分割表示  94 件中 1 - 20 件目  ／  全件表示 >>

  1. Chikada Ayaka, Orimo Kenta, Mitsui Jun, Matsukawa Takashi, Ishiura Hiroyuki, Toda Tatsushi, Mizusawa Hidehiro, Takahashi Yuji, Katsuno Masahisa, Hara Kazuhiro, Onodera Osamu, Ishihara Tomohiko, Tada Masayoshi, Kuwabara Satoshi, Sugiyama Atsuhiko, Yamanaka Yoshitaka, Takahashi Ryosuke, Sawamoto Nobukatsu, Sakato Yusuke, Ishimoto Tomoyuki, Hanajima Ritsuko, Watanabe Yasuhiro, Takigawa Hiroshi, Adachi Tadashi, Abe Koji, Yamashita Toru, Takashima Hiroshi, Higashi Keiko, Kira Junichi, Yabe Ichiro, Matsushima Masaaki, Ogata Katsuhisa, Ishikawa Kinya, Nishida Yoichiro, Ishiguro Taro, Ozaki Kokoro, Nagata Tetsuya, Tsuji Shoji. The Japan MSA registry: A multicenter cohort study of multiple system atrophy(タイトル和訳中) Neurology and Clinical Neuroscience. 2024.09; 12 (5): 271-277. ( 医中誌 )

  2. Takahashi S, Ono D, Shintaku H, Oyama J, Nishida Y, Ishikawa K, Yokota T. Cryptogenic New-onset Refractory Status Epilepticus with Hyperintensity of T1-weighted Magnetic Resonance Imaging in the Bilateral Basal Ganglia: An Autopsy Report. Internal medicine (Tokyo, Japan). 2024.09; ( PubMed, DOI )

  3. Honda T, Matsumura K, Hashimoto Y, Yokota T, Mizusawa H, Nagao S, Ishikawa K. Temporal Relationship between Impairment of Cerebellar Motor Learning and Deterioration of Ataxia in Patients with Cerebellar Degeneration. Cerebellum (London, England). 2024.08; 23 (4): 1280-1292. ( PubMed, DOI )

  4. Wang D, Honda S, Shin MK, Watase K, Mizusawa H, Ishikawa K, Shimizu S. Subcellular localization and ER-mediated cytotoxic function of α1A and α1ACT in spinocerebellar ataxia type 6. Biochemical and biophysical research communications. 2024.02; 695 149481. ( PubMed, DOI )

  5. Rayle Mamuti, Sato Nozomu, Ozaki Kokoro, Higashi Miwa, Okita Michi, Yajima Reiko, Amano Akiko, Mizusawa Hidehiro, Yokota Takanori, Ishikawa Kinya. Degenerative ataxiaの日本人患者167名のコホートを対象とした、多型性を示すSCA37遺伝子座の解析(Analysis of the polymorphic SCA37 locus in a cohort of 167 Japanese patients with degenerative ataxia) Journal of Medical and Dental Sciences. 2024; 71 11-17. ( 医中誌 )

  6. Chang S, Torii S, Inamo J, Ishikawa K, Kochi Y, Shimizu S. Uncovering the Localization and Function of a Novel Read-Through Transcript 'TOMM40-APOE'. Cells. 2023.12; 13 (1): ( PubMed, DOI )

  7. Ishikawa K. How Certain Are You When Making the Diagnosis of Multiple System Atrophy? Neurology. 2023.12; 101 (24): 1081-1082. ( PubMed, DOI )

  8. Inoue K, Asaka M, Lee S, Ishikawa K, Yanagihara D. Gait disorders induced by photothrombotic cerebellar stroke in mice. Scientific reports. 2023.09; 13 (1): 15805. ( PubMed, DOI )

  9. Fujino Y, Ueyama M, Ishiguro T, Ozawa D, Ito H, Sugiki T, Murata A, Ishiguro A, Gendron T, Mori K, Tokuda E, Taminato T, Konno T, Koyama A, Kawabe Y, Takeuchi T, Furukawa Y, Fujiwara T, Ikeda M, Mizuno T, Mochizuki H, Mizusawa H, Wada K, Ishikawa K, Onodera O, Nakatani K, Petrucelli L, Taguchi H, Nagai Y. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD. eLife. 2023.07; 12 ( PubMed, DOI )

  10. Shiwaku, H; Katayama, S; Gao, MX; Kondo, K; Nakano, Y; Motokawa, Y; Toyoda, S; Yoshida, F; Hori, H; Kubota, T; Ishikawa, K; Kunugi, H; Ikegaya, Y; Okazawa, H; Takahashi, H. Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1? in schizophrenia BRAIN BEHAVIOR AND IMMUNITY. 2023.07; 111 32-45. ( PubMed, DOI )

  11. Mitsui, J; Matsukawa, T; Uemura, Y; Kawahara, T; Chikada, A; Porto, KJL; Naruse, H; Tanaka, M; Ishiura, H; Toda, T; Kuzuyama, H; Hirano, M; Wada, I; Ga, T; Moritoyo, T; Takahashi, Y; Mizusawa, H; Ishikawa, K; Yokota, T; Kuwabara, S; Sawamoto, N; Takahashi, R; Abe, K; Ishihara, T; Onodera, O; Matsuse, D; Yamasaki, R; Kira, JI; Katsuno, M; Hanajima, R; Ogata, K; Takashima, H; Matsushima, M; Yabe, I; Sasaki, H; Tsuji, S. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo controlled phase 2 trial ECLINICALMEDICINE. 2023.05; 59 101920. ( PubMed, DOI )

  12. Ishikawa Kinya. 【神経・精神疾患の遺伝学】脊髄小脳失調症31型(SCA31)(【Genetics of neurological and psychiatric disorders】Spinocerebellar ataxia type 31(SCA31)) Journal of Human Genetics. 2023.03; 68 (3): 153-156. ( 医中誌 )

  13. Ishikawa, K. Spinocerebellar ataxia type 31 (SCA31) JOURNAL OF HUMAN GENETICS. 2023.03; 68 (3): 153-156. ( PubMed, DOI )

  14. Hamanaka K, Yamauchi D, Koshimizu E, Watase K, Mogushi K, Ishikawa K, Mizusawa H, Tsuchida N, Uchiyama Y, Fujita A, Misawa K, Mizuguchi T, Miyatake S, Matsumoto N. Genome-wide identification of tandem repeats associated with splicing variation across 49 tissues in humans. Genome research. 2023.03; 33 (3): 435-447. ( PubMed, DOI )

  15. Aoki H, Higashi M, Okita M, Ando N, Murayama S, Ishikawa K, Yokota T. Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)(n). Cerebellum (London, England). 2023.02; 22 (1): 70-84. ( PubMed, DOI )

  16. Saucier J, Al-Qadi M, Amor MB, Ishikawa K, Chamard-Witkowski L. Spinocerebellar ataxia type 31: A clinical and radiological literature review. Journal of the neurological sciences. 2023.01; 444 120527. ( PubMed, DOI )

  17. Zeniya Satoshi, Sanjo Nobuo, Kuwahara Hiroya, Ishikawa Kinya, Higashi Miwa, Matsunaga Akiko, Yoneda Makoto, Mizusawa Hidehiro, Yokota Takanori. 抗アミノ末端α-エノラーゼ自己抗体による脊髄小脳失調症31型の増悪(Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies) Internal Medicine. 2022.09; 61 (18): 2793-2796. ( 医中誌 )

  18. Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, Yoshimura S, Shintaku H, Ishikawa K, Tsuura Y, Iizuka T, Yokota T, Irioka T, Höftberger R. Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies. Neurology(R) neuroimmunology & neuroinflammation. 2022.07; 9 (4): ( PubMed, DOI )

  19. Shiwaku, H; Katayama, S; Kondo, K; Nakano, Y; Tanaka, H; Yoshioka, Y; Fujita, K; Tamaki, H; Takebayashi, H; Terasaki, O; Nagase, Y; Nagase, T; Kubota, T; Ishikawa, K; Okazawa, H; Takahashi, H. Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice CELL REPORTS MEDICINE. 2022.04; 3 (4): 100597. ( PubMed, DOI )

  20. Zeniya S, Sanjo N, Kuwahara H, Ishikawa K, Higashi M, Matsunaga A, Yoneda M, Mizusawa H, Yokota T. Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies. Internal medicine (Tokyo, Japan). 2022; 61 (18): 2793-2796. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲